Veradigm Current Ratio 2011-2022 | MDRX
Veradigm current ratio from 2011 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Veradigm Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2022-12-31 | $0.68B | $0.23B | 2.95 |
| 2022-09-30 | $0.81B | $0.25B | 3.20 |
| 2022-06-30 | $0.83B | $0.26B | 3.23 |
| 2022-03-31 | $1.54B | $0.65B | 2.38 |
| 2021-12-31 | $0.65B | $0.49B | 1.33 |
| 2021-09-30 | $0.81B | $0.57B | 1.42 |
| 2021-06-30 | $0.84B | $0.60B | 1.41 |
| 2021-03-31 | $1.14B | $0.88B | 1.29 |
| 2020-12-31 | $1.15B | $0.94B | 1.23 |
| 2020-09-30 | $0.95B | $0.75B | 1.27 |
| 2020-06-30 | $0.87B | $1.11B | 0.78 |
| 2020-03-31 | $0.91B | $1.16B | 0.78 |
| 2019-12-31 | $0.84B | $1.21B | 0.70 |
| 2019-09-30 | $0.77B | $1.18B | 0.66 |
| 2019-06-30 | $0.80B | $0.88B | 0.91 |
| 2019-03-31 | $0.83B | $0.80B | 1.04 |
| 2018-12-31 | $0.86B | $0.80B | 1.08 |
| 2018-09-30 | $0.84B | $0.89B | 0.94 |
| 2018-06-30 | $0.86B | $0.91B | 0.94 |
| 2018-03-31 | $0.91B | $0.89B | 1.02 |
| 2017-12-31 | $0.86B | $0.89B | 0.96 |
| 2017-09-30 | $0.67B | $0.68B | 0.98 |
| 2017-06-30 | $0.62B | $0.67B | 0.93 |
| 2017-03-31 | $0.63B | $0.70B | 0.90 |
| 2016-12-31 | $0.60B | $0.67B | 0.91 |
| 2016-09-30 | $0.59B | $0.63B | 0.94 |
| 2016-06-30 | $0.59B | $0.61B | 0.98 |
| 2016-03-31 | $0.54B | $0.54B | 0.99 |
| 2015-12-31 | $0.54B | $0.51B | 1.05 |
| 2015-09-30 | $0.55B | $0.49B | 1.12 |
| 2015-06-30 | $0.54B | $0.52B | 1.04 |
| 2015-03-31 | $0.56B | $0.54B | 1.04 |
| 2014-12-31 | $0.49B | $0.52B | 0.93 |
| 2014-09-30 | $0.55B | $0.52B | 1.05 |
| 2014-06-30 | $0.54B | $0.52B | 1.05 |
| 2014-03-31 | $0.54B | $0.53B | 1.02 |
| 2013-12-31 | $0.54B | $0.52B | 1.04 |
| 2013-09-30 | $0.56B | $0.52B | 1.07 |
| 2013-06-30 | $0.59B | $0.54B | 1.10 |
| 2013-03-31 | $0.62B | $0.63B | 0.99 |
| 2012-12-31 | $0.57B | $0.52B | 1.11 |
| 2012-09-30 | $0.63B | $0.54B | 1.17 |
| 2012-06-30 | $0.66B | $0.56B | 1.16 |
| 2012-03-31 | $0.72B | $0.56B | 1.30 |
| 2011-12-31 | $0.66B | $0.50B | 1.32 |
| 2011-09-30 | $0.59B | $0.46B | 1.28 |
| 2011-06-30 | $0.61B | $0.49B | 1.25 |
| 2011-03-31 | $0.60B | $0.45B | 1.32 |
| 2010-12-31 | $0.58B | $0.43B | 1.34 |
| 2010-09-30 | $0.55B | $0.39B | 1.43 |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-05-31 | $0.41B | $0.21B | 1.92 |
| 2010-03-31 | $0.00B | 0.00 | |
| 2010-02-28 | $0.35B | $0.19B | 1.82 |
| 2009-12-31 | $0.29B | $0.16B | 1.87 |
| 2009-11-30 | $0.29B | $0.16B | 1.84 |
| 2009-09-30 | $0.00B | 0.00 | |
| 2009-08-31 | $0.28B | $0.16B | 1.74 |
| 2009-05-31 | $0.26B | $0.16B | 1.59 |
| 2009-02-28 | $0.29B | $0.17B | 1.66 |
| 2008-11-30 | $0.27B | $0.16B | 1.69 |
| 2008-09-30 | $0.20B | $0.10B | 2.07 |
| 2008-08-31 | $0.00B | 0.00 | |
| 2008-06-30 | $0.18B | $0.09B | 2.00 |
| 2008-05-31 | $0.06B | $0.07B | 0.90 |
| 2008-03-31 | $0.18B | $0.09B | 1.90 |
| 2008-02-29 | $0.00B | 0.00 | |
| 2007-12-31 | $0.17B | $0.09B | 1.80 |
| 2007-11-30 | $0.00B | 0.00 | |
| 2007-09-30 | $0.19B | $0.08B | 2.47 |
| 2007-06-30 | $0.18B | $0.07B | 2.51 |
| 2007-05-31 | $0.00B | 0.00 | |
| 2007-03-31 | $0.17B | $0.08B | 2.25 |
| 2006-12-31 | $0.15B | $0.07B | 2.15 |
| 2006-09-30 | $0.12B | $0.07B | 1.64 |
| 2006-06-30 | $0.11B | $0.07B | 1.65 |
| 2006-03-31 | $0.11B | $0.07B | 1.54 |
| 2005-12-31 | $0.15B | $0.04B | 3.85 |
| 2005-09-30 | $0.13B | $0.03B | 4.13 |
| 2005-06-30 | $0.11B | $0.03B | 3.49 |
| 2005-03-31 | $0.09B | $0.03B | 2.78 |
| 2004-12-31 | $0.07B | $0.03B | 2.06 |
| 2004-09-30 | $0.09B | $0.03B | 2.92 |
| 2004-06-30 | $0.05B | $0.03B | 1.80 |
| 2004-03-31 | $0.04B | $0.03B | 1.56 |
| 2003-12-31 | $0.04B | $0.03B | 1.70 |
| 2003-09-30 | $0.04B | $0.02B | 1.69 |
| 2003-06-30 | $0.05B | $0.02B | 2.65 |
| 2003-03-31 | $0.05B | $0.02B | 2.75 |
| 2002-12-31 | $0.06B | $0.02B | 3.42 |
| 2002-09-30 | $0.06B | $0.02B | 3.33 |
| 2002-06-30 | $0.07B | $0.02B | 3.97 |
| 2002-03-31 | $0.07B | $0.02B | 4.06 |
| 2001-12-31 | $0.07B | $0.02B | 3.51 |
| 2001-09-30 | $0.07B | $0.02B | 3.93 |
| 2001-06-30 | $0.08B | $0.01B | 6.50 |
| 2001-03-31 | $0.09B | $0.02B | 3.68 |
| 2000-12-31 | $0.12B | $0.01B | 8.39 |
| 2000-09-30 | $0.12B | $0.02B | 8.31 |
| 2000-06-30 | $0.13B | $0.01B | 10.22 |
| 2000-03-31 | $0.16B | $0.01B | 23.85 |
| 1999-12-31 | $0.07B | $0.01B | 9.93 |
| 1999-09-30 | $0.07B | $0.01B | 10.26 |
| 1999-06-30 | $0.01B | $0.01B | 0.97 |
| 1999-03-31 | $0.02B | $0.02B | 1.31 |
| 1998-12-31 | $0.01B | $0.01B | 1.02 |
| 1998-09-30 | $0.00B | 0.00 | |
| 1998-06-30 | $0.00B | 0.00 | |
| 1997-12-31 | $0.01B | $0.02B | 0.81 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.523B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $12.183B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Inspire Medical Systems (INSP) | United States | $2.509B | 41.51 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $2.011B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.466B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.160B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.045B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |